Vaccine News and Research

Latest Vaccine News and Research

SARS-CoV-2 reinfection risk in the population of the Abruzzo Region of Italy

Researchers evaluated the incidences of SARS-CoV-2 reinfections, hospitalizations, and death among the previously infected population of the Abruzzo region in Italy.

22 Feb 2022

Covid still threatens millions of Americans. Why are we so eager to move on?

Iesha White is so fed up with the U.S. response to covid-19 that she's seriously considering moving to Europe.

22 Feb 2022

Using IgG antibody assay to Identify natural SARS-CoV-2 infection in vaccinees

A recent study published in the journal of Mayo Clinic Proceedings predicted the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) natural infection in vaccinated individuals.

21 Feb 2022

Monitoring rise of SARS-CoV-2 variants in wastewater using genome sequencing

Researchers conduct genomic wastewater surveillance of SARS-CoV-2 following the emergence of the Alpha and Delta variants in the United Kingdom.

21 Feb 2022

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

researchers determine the strong neutralizing mucosal component emanating from intramuscular administration of an mRNA vaccine.

21 Feb 2022

COVID-19 during pregnancy linked to maternal mortality or morbidity from obstetric complications

Pregnant and postpartum individuals infected with SARS-CoV-2 during pregnancy have an increased risk of maternal mortality or morbidity from obstetric complications, according to a recent study published in JAMA.

21 Feb 2022

Health Secretary statement on additional COVID-19 booster jabs from spring

Thanks to our COVID-19 vaccination rollout, we are already the freest country in Europe. It has saved countless lives, reduced pressure on the NHS and is allowing us to learn to live with the virus

21 Feb 2022

Prime Minister sets out the Government's plans to live with and manage COVID

Vaccines will remain the first line of defense against Covid-19 as the Prime Minister sets out the Government's plans to live with and manage the virus.

21 Feb 2022

SARS-CoV-2 Omicron variant prompts system sciences and precision medicine

In a new review study, researchers aimed to describe the emergence of the Omicron variant, its structure, its impact on health and health systems, and the challenges that can be expected due to this variant.

21 Feb 2022

Comparative transmission study of SARS-CoV-2 Omicron and Delta variant in England

Researchers performed an epidemiological cohort study to assess differences in transmission of the SARS-CoV-2 Omicron and Delta variants in England.

21 Feb 2022

Molecular characteristics of SARS-CoV-2 variants enabling antibody escape

A new review paper published in PLoS Pathogens discusses the new variants and the structural mechanism underlying antibody-mediated neutralization as well as mutational antibody escape.

21 Feb 2022

Mathematical model of host immune response to SARS-CoV-2 demonstrates that age-related risk factors increased viral load

Researchers evaluated the host immune responses to SARS-CoV-2 and its prolonged symptoms.

21 Feb 2022

The effect of COVID-19 vaccination on long COVID symptoms

Researchers assessed the effectiveness of COVID-19 vaccines in patients experiencing long COVID.

21 Feb 2022

Mechanisms of IL-6 expression in peripheral monocyte-derived macrophages infected with SARS-CoV-2

Researchers examined the detailed mechanisms of ‘cytokine storm’ that induces ARDS, often resulting in the death of severely ill COVID-19 patients.

21 Feb 2022

Full schedule of CoronaVac vaccine shown to be highly effective in children

A recent study on vaccine effectiveness showed that a complete primary immunization with CoronaVac effectively protects against severe coronavirus disease 2019 (COVID-19) for children and adolescents between 6 and 16 years of age – consistent with the results from phase 2 clinical trials. The paper is currently available on the Preprints with The Lancet* server while it undergoes peer review.

20 Feb 2022

Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate

Researchers have developed a new vaccine candidate that is specifically targeted against the SARS-CoV-2 Omicron variant.

20 Feb 2022

T-cell responses linked with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer

T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer, with lower T-cell responses observed in patients with blood cancers.

18 Feb 2022

Vaccine News and Research

Latest Vaccine News and Research

SARS-CoV-2 reinfection risk in the population of the Abruzzo Region of Italy

Covid still threatens millions of Americans. Why are we so eager to move on?

Using IgG antibody assay to Identify natural SARS-CoV-2 infection in vaccinees

Monitoring rise of SARS-CoV-2 variants in wastewater using genome sequencing

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

COVID-19 during pregnancy linked to maternal mortality or morbidity from obstetric complications

Health Secretary statement on additional COVID-19 booster jabs from spring

Prime Minister sets out the Government's plans to live with and manage COVID

SARS-CoV-2 Omicron variant prompts system sciences and precision medicine

Comparative transmission study of SARS-CoV-2 Omicron and Delta variant in England

Molecular characteristics of SARS-CoV-2 variants enabling antibody escape

Mathematical model of host immune response to SARS-CoV-2 demonstrates that age-related risk factors increased viral load

The effect of COVID-19 vaccination on long COVID symptoms

Mechanisms of IL-6 expression in peripheral monocyte-derived macrophages infected with SARS-CoV-2

Full schedule of CoronaVac vaccine shown to be highly effective in children

Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate

T-cell responses linked with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer

U-M's COVID-19 dashboard: Majority of the campus community up to date on vaccinations

Omicron outbreak in an indoor convention in New York

Study characterizes COVID-19 vaccine effectiveness at longer dose intervals

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in